Status:
COMPLETED
Selfcare MAnagement InteRvenTion in Heart Failure II (SMART HF II)
Lead Sponsor:
Lund University
Conditions:
Heart Failure
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of the study is to evaluate if the digital support and communication platform for heart failure can provide patients with heart failure increased knowledge, compliance and quality of life ...
Eligibility Criteria
Inclusion
- Diagnosed heart failure I.50 (newly discovered or existing) in NYHA Class I-IV in principle with ESC guidelines 2016.
- Have completed the "consent form" or consent form, see §4.2 Exclusion criteria: \* Patient who refuses to participate in the trial.
- It is assessed that they can handle the intervention themselves or with the help of personal or relatives.
Exclusion
- Patient who declines to participate in the trial.
- Impaired cognitive ability that is judged to affect the ability to conduct the study in the intended manner.
- Life expectancy \<8 months
- In other ways, by the treating physician, it is deemed inappropriate to participate in the study, e.g. due to participation in another study.
Key Trial Info
Start Date :
May 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04327128
Start Date
May 29 2019
End Date
April 30 2021
Last Update
July 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lund University
Lund, Skåne County, Sweden, 22100